Israel Englander Sol Gel Technologies Ltd. Transaction History

Millennium Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.66 - $1.05 $5,345 - $8,503	-8,099 Reduced 39.7%	12,301 $10,000
Q1 2024 May 15, 2024	BUY	$0.95 - $1.5 $7,374 - $11,644	7,763 Added 61.43%	20,400 $19,000
Q4 2023 Feb 14, 2024	BUY	$0.92 - $1.6 $11,626 - $20,219	12,637 New	12,637 $13,000
Q2 2020 Aug 14, 2020	SELL	$6.15 - $9.4 $69,212 - $105,787	-11,254 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$5.88 - $15.75 $66,173 - $177,250	11,254 New	11,254 $79,000

5.35M

1.5K

Ticker SLGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,129,500
Market Cap $10.2M
Description
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.